Genen Pharmaceuticals Co.,Ltd
- Contact:Ada Wang
- Tel: 852-281-13620
- Mail: sales@genen-pharma.com
Main product: advanced and key pharmaceutical intermediates and relevant API/production, R&D
All products
-
Carfilzomib (868540-17-4)
-
Bortezomib (179324-69-7)
-
(aR,3aS,4S,6S,7aR)-H (179324-87-9)
-
4,6-Methano-1,3,2-be (779357-85-6)
-
entecavir (142217-69-4)
-
Paclitaxel (33069-62-4)
-
Taxotere (114977-28-5)
-
5-Chloro-N-[[[4-[6-f (936500-94-6)
-
4'-[(2-Butyl-4-oxo-1 (138401-24-8)
-
Olaparib (763113-22-0)
-
(586379-66-0)
-
Talabostat mesylate (150080-09-4)
-
1-Pyrrolidinecarboxy (149682-75-7)
-
Pyrrolidine,2-[(3aS, (147208-69-3)
-
2-Pyridinamine,3-[(1 (877399-52-5)
-
CEP 18770 (847499-27-8)
-
PF-06463922 (1454846-35-5)
-
4(3H)-Quinazolinone, (24159-07-7)
-
3-(1-Biphenyl-4-ylMe (936623-90-4)
-
Nolatrexed (147149-76-6)